Your browser doesn't support javascript.
Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.
Emerg Infect Dis ; 29(6): 1154-1161, 2023 06.
Artículo en Inglés | MEDLINE | ID: covidwho-2318660
ABSTRACT
Centers for Disease Control and Prevention guidelines consider SARS-CoV-2 reinfection when sequential COVID-19 episodes occur >90 days apart. However, genomic diversity acquired over recent COVID-19 waves could mean previous infection provides insufficient cross-protection. We used genomic analysis to assess the percentage of early reinfections in a sample of 26 patients with 2 COVID-19 episodes separated by 20-45 days. Among sampled patients, 11 (42%) had reinfections involving different SARS-CoV-2 variants or subvariants. Another 4 cases were probable reinfections; 3 involved different strains from the same lineage or sublineage. Host genomic analysis confirmed the 2 sequential specimens belonged to the same patient. Among all reinfections, 36.4% involved non-Omicron, then Omicron lineages. Early reinfections showed no specific clinical patterns; 45% were among unvaccinated or incompletely vaccinated persons, 27% were among persons <18 years of age, and 64% of patients had no risk factors. Time between sequential positive SARS-CoV-2 PCRs to consider reinfection should be re-evaluated.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Reinfección / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas / Variantes Límite: Humanos País/Región como asunto: America del Norte / Europa Idioma: Inglés Revista: Emerg Infect Dis Asunto de la revista: Enfermedades Transmisibles Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Reinfección / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas / Variantes Límite: Humanos País/Región como asunto: America del Norte / Europa Idioma: Inglés Revista: Emerg Infect Dis Asunto de la revista: Enfermedades Transmisibles Año: 2023 Tipo del documento: Artículo